tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Paraproteinemias D010265 2 associated lipids
Amputation, Traumatic D000673 2 associated lipids
Neuromyelitis Optica D009471 2 associated lipids
Pharyngitis D010612 2 associated lipids
Carcinoma, Merkel Cell D015266 2 associated lipids
Fungemia D016469 2 associated lipids
Digestive System Diseases D004066 3 associated lipids
Pemphigus, Benign Familial D016506 3 associated lipids
Ileus D045823 3 associated lipids
Anemia, Refractory D000753 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Pityriasis D010915 3 associated lipids
Uveitis, Intermediate D015867 3 associated lipids
Legionellosis D007876 3 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Hematologic Diseases D006402 3 associated lipids
Glomerulonephritis, Membranoproliferative D015432 3 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Perceptual Disorders D010468 3 associated lipids
Toxocariasis D014120 3 associated lipids
Pyoderma Gangrenosum D017511 3 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Lichen Planus D008010 3 associated lipids
Trichomonas Infections D014245 3 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Impetigo D007169 3 associated lipids
Polyneuropathies D011115 3 associated lipids
Nervous System Autoimmune Disease, Experimental D020721 3 associated lipids
Epidermolysis Bullosa D004820 3 associated lipids
Paronychia D010304 3 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Facial Neoplasms D005153 3 associated lipids
Gingivitis D005891 3 associated lipids
Hemophilia B D002836 3 associated lipids
Pouchitis D019449 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Meningococcal Infections D008589 3 associated lipids
Pemphigus D010392 3 associated lipids
Dysgammaglobulinemia D004406 3 associated lipids
Pterygium D011625 3 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Intestinal Atresia D007409 3 associated lipids
Foot Dermatoses D005533 3 associated lipids
Hyperkalemia D006947 3 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Cryptogenic Organizing Pneumonia D018549 3 associated lipids
Immune System Diseases D007154 3 associated lipids
Cardiovirus Infections D018188 3 associated lipids
Acneiform Eruptions D017486 3 associated lipids
Osteochondrodysplasias D010009 3 associated lipids
Anus Diseases D001004 3 associated lipids
Leprosy, Borderline D015439 3 associated lipids
Castleman Disease D005871 3 associated lipids
Scleritis D015423 3 associated lipids
Kidney Tubular Necrosis, Acute D007683 3 associated lipids
Diabetes Complications D048909 4 associated lipids
Balanitis D001446 4 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Amenorrhea D000568 4 associated lipids
Blepharitis D001762 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Hallucinations D006212 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Herpesviridae Infections D006566 4 associated lipids
Prurigo D011536 4 associated lipids
Viremia D014766 4 associated lipids
Gastroenteritis D005759 4 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Gout D006073 4 associated lipids
Ovarian Cysts D010048 4 associated lipids
Pemphigoid, Benign Mucous Membrane D010390 4 associated lipids
Papillomavirus Infections D030361 4 associated lipids
Confusion D003221 4 associated lipids
Parotitis D010309 4 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Bone Diseases D001847 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Foot Ulcer D016523 4 associated lipids
Neoplasms, Second Primary D016609 4 associated lipids
Eczema D004485 4 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Red-Cell Aplasia, Pure D012010 4 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Morita H et al. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells. 2000 Transplant. Proc. pmid:10715422
Vela CG et al. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. 2000 Transplant. Proc. pmid:10715453
Dunnett SB The failure of axon regeneration in the CNS is not absolute. 1999 Neuroreport pmid:10716198
Sugawara T et al. Immunosuppressants promote adult dorsal root regeneration into the spinal cord. 1999 Neuroreport pmid:10716239
Campbell G et al. Spontaneous axonal regeneration after optic nerve injury in adult rat. 1999 Neuroreport pmid:10716240
Smythe GM et al. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. 2000 Muscle Nerve pmid:10716768
Lee M et al. FK506 promotes functional recovery in crushed rat sciatic nerve. 2000 Muscle Nerve pmid:10716776
Carr DB et al. Maternal hemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. 2000 Liver Transpl. pmid:10719023
Hale GA et al. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. 2000 Bone Marrow Transplant. pmid:10723590
Inomata Y et al. [Weaning of immunosuppression in living-related liver transplantation]. 1999 Nihon Rinsho Meneki Gakkai Kaishi pmid:10726480
Konrad T et al. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation. 2000 Metab. Clin. Exp. pmid:10726916
Fukuda H et al. Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A. 2000 Int. J. Hematol. pmid:10729997
Plosker GL and Foster RH Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. 2000 Drugs pmid:10730553
Bargalló N et al. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. 2000 AJNR Am J Neuroradiol pmid:10730638
Ierardi E et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. 2000 J. Clin. Gastroenterol. pmid:10730928
Sigalet DL et al. Impact of FK506 and steroids on adaptation after intestinal resection or segmental transplantation. 2000 Pediatr Transplant pmid:10731053
Pappas PA et al. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy. 2000 Pediatr Transplant pmid:10731058
Eades SK et al. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. 2000 Pediatr Transplant pmid:10731062
Squadrito F et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury. 2000 J. Mol. Cell. Cardiol. pmid:10731442
Prima V et al. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds. 2000 Jan-Feb J. Steroid Biochem. Mol. Biol. pmid:10731632
Adalsteinsson H and Bruice TC Generation and evaluation of putative neuroregenerative drugs. Part 1: virtual point mutations to the polyketide rapamycin. 2000 Bioorg. Med. Chem. pmid:10732978
Kawai T et al. FK506-induced autoimmune diabetes. 2000 Ann. Intern. Med. pmid:10733461
Wong KM et al. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. 2000 Am. J. Kidney Dis. pmid:10739787
Böhmig GA et al. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. 2000 Am. J. Kidney Dis. pmid:10739788
Li ST et al. High Ca(2+)/low Mg(2+) solution induces long-term depression in rat CA1 pyramidal neurons. 2000 Neurosci. Lett. pmid:10739895
Dubowchik GM et al. Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay. 2000 Bioorg. Med. Chem. Lett. pmid:10741553
Weidelt T and Isenberg G Augmentation of SR Ca(2+) release by rapamycin and FK506 causes K(+)-channel activation and membrane hyperpolarization in bladder smooth muscle. 2000 Br. J. Pharmacol. pmid:10742283
Yoshida EM et al. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. 2000 Transpl. Int. pmid:10743693
Emre S et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. 2000 Transpl. Int. pmid:10743694
Skuk D et al. Myoblast transplantation in whole muscle of nonhuman primates. 2000 J. Neuropathol. Exp. Neurol. pmid:10744058
Gaziev D et al. Chronic graft-versus-host disease: is there an alternative to the conventional treatment? 2000 Bone Marrow Transplant. pmid:10745252
Minematsu T et al. Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs. 1999 Biol. Pharm. Bull. pmid:10746167
Chiou WL et al. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. 2000 Pharm. Res. pmid:10751036
Shimizu T et al. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts. 1999 Clin Transplant pmid:10751057
Wang MS and Gold BG FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. 1999 J Spinal Cord Med pmid:10751133
Davis DL et al. Biochemical characterization of the minor immunophilins. 2000 Clin. Biochem. pmid:10751584
Freeman EE and Grosskreutz CL The effects of FK506 on retinal ganglion cells after optic nerve crush. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10752948
Harmon JD et al. Stuttering priapism in a liver transplant patient with toxic levels of fk506. 1999 Urology pmid:10754131
Johnson C et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. 2000 Transplantation pmid:10755536
Miller J et al. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. 2000 Transplantation pmid:10755543
Mohamed MA et al. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. 2000 Transplantation pmid:10755567
Kano S et al. [Role of FK506-binding protein (FKBP) in Ca+ oscillation in bronchial epithelial cells]. 2000 Jpn J Antibiot pmid:10756444
Takahashi N [Macrolide compounds as inhibitors of the intracellular signal transmission pathway: the mechanism of actions of rapamycin and FK506]. 2000 Jpn J Antibiot pmid:10756454
Yamamoto K et al. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. 2000 Hum. Gene Ther. pmid:10757347
Minervini MI et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). 2000 Am. J. Surg. Pathol. pmid:10757402
Tchah H and Lim B Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model. 1999 Korean J Ophthalmol pmid:10761401
Thorp M et al. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. 2000 Transplantation pmid:10762229
Nevins TE Overview of new immunosuppressive therapies. 2000 Curr. Opin. Pediatr. pmid:10763765
Gordjani N et al. Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms. 2000 Pflugers Arch. pmid:10764223